14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AMTI
Delisted

Applied Molecular Transport Inc. Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.263
+0 (+0%)
At Close: Mar 25, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 25th Mar 2024 AMTI stock ended at $0.263. During the day the stock fluctuated 0% from a day low at $0.263 to a day high of $0.263.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Applied Molecular Transport Inc. prices

Date Open High Low Close Volume
Mar 25, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 22, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 21, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 20, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 19, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 18, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 15, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 14, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 13, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 12, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 11, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 08, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 07, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 06, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 05, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 04, 2024 $0.263 $0.263 $0.263 $0.263 0
Mar 01, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 29, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 28, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 27, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 26, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 23, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 22, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 21, 2024 $0.263 $0.263 $0.263 $0.263 0
Feb 20, 2024 $0.263 $0.263 $0.263 $0.263 0
Click to get the best stock tips daily for free!

About Applied Molecular Transport Inc.

Applied Molecular Transport. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammat... AMTI Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT